A few years ago, the biggest challenge in genomics was generating sequencing data.

Today, that's no longer the case.

Modern Next-Generation Sequencing (NGS) technologies can produce millions of sequencing reads in just a few hours. But once the data is generated, another challenge begins making sense of thousands of genetic variants.

Which variants are disease-causing? Which are harmless? Which deserve further investigation?

Finding those answers still takes time, especially when annotation is done manually.

As sequencing projects continue to grow, manual variant annotation has become one of the biggest bottlenecks in modern bioinformatics.

Fortunately, a new generation of AI-assisted annotation tools is changing that.

Why Manual Variant Annotation No Longer Works at Scale

Every WES, WGS, or Variant Calling project generates thousands of variants.

To interpret them, researchers often switch between multiple databases, compare published studies, and manually collect evidence before reaching a conclusion. Every variant requires careful review, and even experienced bioinformaticians can spend hours gathering the information needed for a single analysis.

For every important variant, they may need to review information from:

• ClinVar
• dbSNP
• gnomAD
• Ensembl
• Published scientific literature

Now imagine repeating that process thousands of times.

The result isn't just slower analysis. It's less time for biological interpretation, research, and scientific discovery. As sequencing volumes continue to increase, manual annotation simply becomes too difficult to scale.

The Hidden Cost of Manual Workflows

Manual annotation affects more than turnaround time.

It also impacts productivity, consistency, and research efficiency. When researchers spend hours searching databases and reviewing literature, less time is available for experimental design, data interpretation, and publishing meaningful results.

Common challenges include:

• Longer analysis timelines
• Repetitive database searches
• Inconsistent interpretation across projects
• Difficulty keeping up with newly published evidence
• Increased workload for bioinformatics teams

As genomic datasets continue to expand, these challenges become even harder to manage. The larger the project, the greater the impact of manual workflows on overall research productivity.

What's Replacing Manual Variant Annotation?

The answer isn't replacing scientists.

It's replacing repetitive work.

Today's bioinformatics platforms combine automation, AI, and continuously updated genomic databases to streamline the annotation process. Instead of manually collecting evidence from different sources, researchers receive comprehensive annotations through a single, standardized workflow.

Instead of searching every resource manually, researchers receive consolidated variant information in one place, including clinical evidence, population frequency, functional predictions, and disease associations.

The result is faster, more consistent, and more scalable genomic analysis without compromising scientific accuracy.

AI Helps Scientists Work Smarter

Artificial Intelligence isn't making scientific decisions.

Researchers still validate findings and provide the biological context that machines can't, following internationally recognized ACMG/AMP variant interpretation guidelines.

What AI does exceptionally well is analyzing large datasets, identifying meaningful patterns, and reducing repetitive analytical work. This allows scientists to focus on understanding the biological significance of a variant rather than spending hours collecting supporting evidence.

AI helps by:

• Prioritizing clinically relevant variants
• Identifying known disease-associated mutations
• Highlighting variants that require further investigation
• Bringing together evidence from multiple trusted sources
• Reducing repetitive manual analysis

Rather than replacing expertise, AI gives researchers more time to apply it where it matters most.

Faster Annotation Leads to Faster Discoveries

When annotation becomes more efficient, the entire research workflow benefits.

Scientists can spend less time searching databases and more time focusing on answering complex biological questions. Faster annotation also improves collaboration, shortens project timelines, and helps laboratories process more samples without significantly increasing manual effort.

This benefits areas such as:

• Rare disease research
• Cancer genomics
• Bulk Transcriptomics (RNA-Seq)
• Biomarker discovery
• Precision medicine
• Multi-omics research

The goal isn't simply to analyze data faster. It's to accelerate meaningful scientific discoveries that can improve research and patient outcomes.

Few examples of these are implemented in variant workflow:

Clinical Workflow Integration

Ruzicka, J., Ravel, J.-M., Audoux, J., Boulat, A., Thévenon, J., Yauy, K., Dancer, M., Raymond, L., Lombardi, Y., Philippe, N., et al. "Integration of Machine Learning-Based Pathogenicity Prediction and Phenotype Matching Improves Variant Prioritization in Rare Clinical Testing." Human Genomics (MDPI), 2026. https://www.mdpi.com/1467-3045/48/7/706
(This is the DiagAI paper - combines a pathogenicity model called UP2 with HPO-based phenotype matching via PhenoGenius, benchmarked against Exomiser v13 and AI-MARRVEL.)

Kim, H.H., Kim, D.-W., Woo, J., Lee, K. "Explicable prioritization of genetic variants by integration of rule-based and machine learning algorithms for diagnosis of rare Mendelian disorders." Human Genomics, 2024;18:31. DOI: 10.1186/s40246-024-00595-8
(The 3ASC system - random forest classifier annotating ACMG/AMP criteria, achieving 85.6% top-1 recall on causative variants.)

Landscape Papers

Pakpahan, I., Sihombing, M., Liu, H., Wang, M., Su, Z., Fang, M. "Harnessing artificial intelligence for genomic variant prediction: advances, challenges, and future directions." GigaScience, Volume 15, 2026, giag004. DOI: 10.1093/gigascience/giag004

Molotkov, I., Mardis, E.R., Artomov, M. "Making sense of missense: challenges and opportunities in variant pathogenicity prediction." Disease Models & Mechanisms, 2024;17(12):dmm052218. DOI: 10.1242/dmm.052218

The Future of Variant Annotation

Genomic data is growing faster than ever.

The laboratories that stay ahead won't be the ones generating the most data—they'll be the ones interpreting it most efficiently. As sequencing technologies continue to evolve, intelligent automation will become an essential part of every modern bioinformatics workflow.

AI-assisted variant annotation is helping make that possible by reducing manual effort, improving consistency, and accelerating genomic analysis.

At GenomeBeans, we combine automated bioinformatics workflows with expert scientific review to deliver accurate, scalable, and publication-ready variant annotation. Because the future of bioinformatics isn't about replacing scientists. It's about helping them discover more, faster.